Skip to content

Explore Courses | Elder Research | Contact | LMS Login

Statistics.com Logo
  • Courses
    • See All Courses
    • Calendar
    • Intro stats for college credit
    • Faculty
    • Group training
    • Credit & Credentialing
    • Teach With Us
  • Programs/Degrees
    • Certificates
      • Analytics for Data Science
      • Biostatistics
      • Programming For Data Science – Python (Experienced)
      • Programming For Data Science – Python (Novice)
      • Programming For Data Science – R (Experienced)
      • Programming For Data Science – R (Novice)
      • Social Science
    • Undergraduate Degree Programs
    • Graduate Degree Programs
    • Massive Open Online Courses (MOOC)
  • Partnerships
    • Higher Education
    • Enterprise
  • Resources
    • About Us
    • Blog
    • Word Of The Week
    • News and Announcements
    • Newsletter signup
    • Glossary
    • Statistical Symbols
    • FAQs & Knowledge Base
    • Testimonials
    • Test Yourself
Menu
  • Courses
    • See All Courses
    • Calendar
    • Intro stats for college credit
    • Faculty
    • Group training
    • Credit & Credentialing
    • Teach With Us
  • Programs/Degrees
    • Certificates
      • Analytics for Data Science
      • Biostatistics
      • Programming For Data Science – Python (Experienced)
      • Programming For Data Science – Python (Novice)
      • Programming For Data Science – R (Experienced)
      • Programming For Data Science – R (Novice)
      • Social Science
    • Undergraduate Degree Programs
    • Graduate Degree Programs
    • Massive Open Online Courses (MOOC)
  • Partnerships
    • Higher Education
    • Enterprise
  • Resources
    • About Us
    • Blog
    • Word Of The Week
    • News and Announcements
    • Newsletter signup
    • Glossary
    • Statistical Symbols
    • FAQs & Knowledge Base
    • Testimonials
    • Test Yourself
Student Login

Blog

Home Blog Industry Spotlight: Clinical Trials

Industry Spotlight: Clinical Trials

 “Complete Your Clinical Trial With Our File Data”

Clinical trials that support new drug development can cost over a billion dollars.  A new industry has popped up – data collectors and aggregators that provide digital data from their files as evidence in pharmaceutical clinical trials.

The gold standard in a clinical trial is the randomized controlled experiment.  In the classic design, one group is given a new drug therapy, while another group is given a placebo or, more likely, the standard prevailing therapy.  Evidence of how a completely new drug performs typically must be derived from the treatment group in an expensive experiment. However, companies are now offering vast stores of data from which the control group may be drawn.

Iqvia, Inc. collects and markets prescription and health data, and has several projects underway in which this information is provided to pharmaceutical companies involved in clinical trials.  Patient recruitment is a big expense in clinical trials, and is unavoidable for the patient group that is receiving a new drug therapy. However, for the control group, a company like Iqvia can supply data on how patients on a standard existing therapy are doing, yielding big savings on several fronts:

  • lower patient recruitment costs 
  • lower administration costs (fewer patients overall)
  • faster time to market

These savings are amplified for relatively rare diseases, where patgient recruitment takes longer.

Two other companies with a similar line of business were recently acquired by Roche Pharmaceutical:

  • Flatiron collects data on cancer treatments from software that it provides to cancer clinics
  • Foundation Medicine obtains data on patients’ cancer tumors from its laboratory testing

Some analysts sound a note of caution – the beauty of a RCT is its ability, via randomization, to wash out factors not related to the treatment being tested. When the control group is not subject to the same conditions as the treatment group, this assurance is lost.  However, data gained from files, as opposed to a “live” control group, may still be “good enough,” particularly when taken in conjunction with other evidence. In 2016, the U.S. Congress mandated that the FDA actively consider alternative sources of data, other than strict RCT’s, as a basis for drug approval.

Recent Posts

  • Oct 6: Ethical AI: Darth Vader and the Cowardly Lion
    /
    0 Comments
  • Oct 19: Data Literacy – The Chainsaw Case
    /
    0 Comments
  • Data Literacy – The Chainsaw Case
    /
    0 Comments

About Statistics.com

Statistics.com offers academic and professional education in statistics, analytics, and data science at beginner, intermediate, and advanced levels of instruction. Statistics.com is a part of Elder Research, a data science consultancy with 25 years of experience in data analytics.

 The Institute for Statistics Education is certified to operate by the State Council of Higher Education for Virginia (SCHEV)

Our Links

  • Contact Us
  • Site Map
  • Explore Courses
  • About Us
  • Management Team
  • Contact Us
  • Site Map
  • Explore Courses
  • About Us
  • Management Team

Social Networks

Facebook Twitter Youtube Linkedin

Contact

The Institute for Statistics Education
2107 Wilson Blvd
Suite 850 
Arlington, VA 22201
(571) 281-8817

ourcourses@statistics.com

  • Contact Us
  • Site Map
  • Explore Courses
  • About Us
  • Management Team

© Copyright 2023 - Statistics.com, LLC | All Rights Reserved | Privacy Policy | Terms of Use

By continuing to use this website, you consent to the use of cookies in accordance with our Cookie Policy.

Accept